nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—melanoma—skin cancer	0.414	0.562	CtDrD
Bleomycin—germ cell cancer—skin cancer	0.323	0.438	CtDrD
Bleomycin—LIG3—Resolution of AP sites via the single-nucleotide replacement pathway—XRCC1—skin cancer	0.0135	0.125	CbGpPWpGaD
Bleomycin—LIG3—Base Excision Repair—XRCC1—skin cancer	0.00938	0.0867	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—POLH—skin cancer	0.00746	0.069	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—MSH2—skin cancer	0.00587	0.0542	CbGpPWpGaD
Bleomycin—BLMH—hair follicle—skin cancer	0.00576	0.104	CbGeAlD
Bleomycin—LIG1—Global Genomic NER (GG-NER)—XPA—skin cancer	0.00574	0.0531	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—XPA—skin cancer	0.00566	0.0523	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—MLH1—skin cancer	0.00529	0.0489	CbGpPWpGaD
Bleomycin—LIG1—Nucleotide Excision Repair—XPA—skin cancer	0.00421	0.039	CbGpPWpGaD
Bleomycin—BLMH—nipple—skin cancer	0.0039	0.0708	CbGeAlD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH2—skin cancer	0.0039	0.0361	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH2—skin cancer	0.0039	0.0361	CbGpPWpGaD
Bleomycin—LIG3—connective tissue—skin cancer	0.0037	0.0672	CbGeAlD
Bleomycin—LIG1—MMR—MSH2—skin cancer	0.0037	0.0342	CbGpPWpGaD
Bleomycin—LIG1—Base Excision Repair—XRCC1—skin cancer	0.00364	0.0336	CbGpPWpGaD
Bleomycin—LIG3—epithelium—skin cancer	0.00352	0.0638	CbGeAlD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MLH1—skin cancer	0.00351	0.0325	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MLH1—skin cancer	0.00351	0.0325	CbGpPWpGaD
Bleomycin—LIG1—connective tissue—skin cancer	0.00343	0.0622	CbGeAlD
Bleomycin—LIG1—MMR—MLH1—skin cancer	0.00334	0.0309	CbGpPWpGaD
Bleomycin—LIG1—skin of body—skin cancer	0.0031	0.0561	CbGeAlD
Bleomycin—LIG1—DNA Repair—POLH—skin cancer	0.0029	0.0268	CbGpPWpGaD
Bleomycin—LIG1—mammalian vulva—skin cancer	0.00282	0.0512	CbGeAlD
Bleomycin—LIG3—lymphoid tissue—skin cancer	0.00271	0.0491	CbGeAlD
Bleomycin—LIG3—female reproductive system—skin cancer	0.00261	0.0474	CbGeAlD
Bleomycin—Skin toxicity—Docetaxel—skin cancer	0.00261	0.027	CcSEcCtD
Bleomycin—LIG1—lymphoid tissue—skin cancer	0.00251	0.0454	CbGeAlD
Bleomycin—BLMH—skin of body—skin cancer	0.0025	0.0453	CbGeAlD
Bleomycin—LIG1—female reproductive system—skin cancer	0.00242	0.0438	CbGeAlD
Bleomycin—BLMH—mammalian vulva—skin cancer	0.00228	0.0413	CbGeAlD
Bleomycin—LIG3—DNA Repair—XRCC1—skin cancer	0.00225	0.0208	CbGpPWpGaD
Bleomycin—Scleroderma—Docetaxel—skin cancer	0.00222	0.023	CcSEcCtD
Bleomycin—LIG1—DNA Repair—XPA—skin cancer	0.00219	0.0203	CbGpPWpGaD
Bleomycin—LIG3—head—skin cancer	0.00218	0.0396	CbGeAlD
Bleomycin—Nail changes—Docetaxel—skin cancer	0.00207	0.0215	CcSEcCtD
Bleomycin—BLMH—lymphoid tissue—skin cancer	0.00202	0.0367	CbGeAlD
Bleomycin—LIG1—head—skin cancer	0.00202	0.0366	CbGeAlD
Bleomycin—LIG3—DNA Repair—MSH2—skin cancer	0.002	0.0185	CbGpPWpGaD
Bleomycin—LIG1—Sorafenib—Vismodegib—skin cancer	0.00196	0.584	CbGdCrCtD
Bleomycin—BLMH—female reproductive system—skin cancer	0.00195	0.0354	CbGeAlD
Bleomycin—LIG3—DNA Repair—MLH1—skin cancer	0.0018	0.0167	CbGpPWpGaD
Bleomycin—Induration—Imiquimod—skin cancer	0.00169	0.0175	CcSEcCtD
Bleomycin—BLMH—head—skin cancer	0.00163	0.0296	CbGeAlD
Bleomycin—LIG3—lymph node—skin cancer	0.00153	0.0277	CbGeAlD
Bleomycin—LIG1—lymph node—skin cancer	0.00141	0.0256	CbGeAlD
Bleomycin—LIG1—Paclitaxel—Docetaxel—skin cancer	0.00139	0.416	CbGdCrCtD
Bleomycin—Local reaction—Imiquimod—skin cancer	0.00136	0.0141	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Imiquimod—skin cancer	0.00127	0.0132	CcSEcCtD
Bleomycin—LIG1—Extension of Telomeres—TERT—skin cancer	0.00118	0.0109	CbGpPWpGaD
Bleomycin—BLMH—lymph node—skin cancer	0.00114	0.0207	CbGeAlD
Bleomycin—LIG1—Global Genomic NER (GG-NER)—ERCC2—skin cancer	0.00111	0.0102	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—ERCC2—skin cancer	0.00109	0.0101	CbGpPWpGaD
Bleomycin—Myelosuppression—Dactinomycin—skin cancer	0.00107	0.0111	CcSEcCtD
Bleomycin—Pulmonary fibrosis—Temozolomide—skin cancer	0.00103	0.0107	CcSEcCtD
Bleomycin—Myelosuppression—Temozolomide—skin cancer	0.000965	0.01	CcSEcCtD
Bleomycin—Hyperaesthesia—Imiquimod—skin cancer	0.000962	0.00997	CcSEcCtD
Bleomycin—Myelosuppression—Fluorouracil—skin cancer	0.000889	0.00921	CcSEcCtD
Bleomycin—LIG1—Transcription-coupled NER (TC-NER)—ERCC2—skin cancer	0.000884	0.00818	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—XRCC1—skin cancer	0.000874	0.00808	CbGpPWpGaD
Bleomycin—Tenderness—Imiquimod—skin cancer	0.000865	0.00897	CcSEcCtD
Bleomycin—Febrile neutropenia—Dactinomycin—skin cancer	0.000831	0.00862	CcSEcCtD
Bleomycin—Weight decreased—Vismodegib—skin cancer	0.000813	0.00843	CcSEcCtD
Bleomycin—LIG1—Nucleotide Excision Repair—ERCC2—skin cancer	0.000812	0.00751	CbGpPWpGaD
Bleomycin—Ulcer—Imiquimod—skin cancer	0.000798	0.00827	CcSEcCtD
Bleomycin—LIG1—DNA Repair—MSH2—skin cancer	0.000775	0.00717	CbGpPWpGaD
Bleomycin—Local reaction—Fluorouracil—skin cancer	0.000753	0.0078	CcSEcCtD
Bleomycin—Febrile neutropenia—Temozolomide—skin cancer	0.000752	0.00779	CcSEcCtD
Bleomycin—Skin exfoliation—Imiquimod—skin cancer	0.000721	0.00747	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Fluorouracil—skin cancer	0.000701	0.00726	CcSEcCtD
Bleomycin—LIG1—DNA Repair—MLH1—skin cancer	0.000698	0.00646	CbGpPWpGaD
Bleomycin—Febrile neutropenia—Fluorouracil—skin cancer	0.000693	0.00718	CcSEcCtD
Bleomycin—Pulmonary fibrosis—Docetaxel—skin cancer	0.000684	0.00709	CcSEcCtD
Bleomycin—Arthritis—Vemurafenib—skin cancer	0.000661	0.00685	CcSEcCtD
Bleomycin—Nail disorder—Fluorouracil—skin cancer	0.000643	0.00666	CcSEcCtD
Bleomycin—Myelosuppression—Docetaxel—skin cancer	0.000641	0.00665	CcSEcCtD
Bleomycin—Interstitial lung disease—Temozolomide—skin cancer	0.000639	0.00662	CcSEcCtD
Bleomycin—Alopecia—Vismodegib—skin cancer	0.000636	0.00659	CcSEcCtD
Bleomycin—Injury—Imiquimod—skin cancer	0.000596	0.00618	CcSEcCtD
Bleomycin—Hyperaesthesia—Temozolomide—skin cancer	0.000576	0.00597	CcSEcCtD
Bleomycin—Extravasation—Dactinomycin—skin cancer	0.000573	0.00594	CcSEcCtD
Bleomycin—Arthritis—Imiquimod—skin cancer	0.000564	0.00584	CcSEcCtD
Bleomycin—Cerebrovascular accident—Imiquimod—skin cancer	0.000559	0.00579	CcSEcCtD
Bleomycin—Mucosal inflammation—Docetaxel—skin cancer	0.000543	0.00563	CcSEcCtD
Bleomycin—LIG1—Telomere Maintenance—TERT—skin cancer	0.000534	0.00494	CbGpPWpGaD
Bleomycin—Myalgia—Vismodegib—skin cancer	0.000533	0.00553	CcSEcCtD
Bleomycin—Ulcer—Dactinomycin—skin cancer	0.000529	0.00548	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Docetaxel—skin cancer	0.000506	0.00524	CcSEcCtD
Bleomycin—Weight decreased—Vemurafenib—skin cancer	0.000502	0.00521	CcSEcCtD
Bleomycin—Febrile neutropenia—Docetaxel—skin cancer	0.0005	0.00518	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000479	0.00443	CbGpPWpGaD
Bleomycin—Tenderness—Fluorouracil—skin cancer	0.000478	0.00495	CcSEcCtD
Bleomycin—Extravasation—Fluorouracil—skin cancer	0.000478	0.00495	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Vismodegib—skin cancer	0.000466	0.00483	CcSEcCtD
Bleomycin—Nail disorder—Docetaxel—skin cancer	0.000464	0.00481	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000454	0.0042	CbGpPWpGaD
Bleomycin—Pancytopenia—Imiquimod—skin cancer	0.00045	0.00466	CcSEcCtD
Bleomycin—LIG1—Chromosome Maintenance—TERT—skin cancer	0.000445	0.00411	CbGpPWpGaD
Bleomycin—Decreased appetite—Vismodegib—skin cancer	0.000444	0.0046	CcSEcCtD
Bleomycin—Ulcer—Fluorouracil—skin cancer	0.000441	0.00457	CcSEcCtD
Bleomycin—Pain—Vismodegib—skin cancer	0.000437	0.00453	CcSEcCtD
Bleomycin—Skin exfoliation—Temozolomide—skin cancer	0.000432	0.00448	CcSEcCtD
Bleomycin—Interstitial lung disease—Docetaxel—skin cancer	0.000425	0.0044	CcSEcCtD
Bleomycin—LIG1—DNA Repair—ERCC2—skin cancer	0.000423	0.00391	CbGpPWpGaD
Bleomycin—Phlebitis—Dactinomycin—skin cancer	0.000421	0.00437	CcSEcCtD
Bleomycin—BLMH—Immune System—TLR7—skin cancer	0.000419	0.00387	CbGpPWpGaD
Bleomycin—Acute coronary syndrome—Imiquimod—skin cancer	0.000416	0.00431	CcSEcCtD
Bleomycin—Myocardial infarction—Imiquimod—skin cancer	0.000414	0.00429	CcSEcCtD
Bleomycin—Chills—Vemurafenib—skin cancer	0.000399	0.00413	CcSEcCtD
Bleomycin—Alopecia—Vemurafenib—skin cancer	0.000393	0.00407	CcSEcCtD
Bleomycin—Erythema—Vemurafenib—skin cancer	0.000387	0.00401	CcSEcCtD
Bleomycin—Haemoglobin—Imiquimod—skin cancer	0.000381	0.00395	CcSEcCtD
Bleomycin—Haemorrhage—Imiquimod—skin cancer	0.000379	0.00393	CcSEcCtD
Bleomycin—Asthenia—Vismodegib—skin cancer	0.000367	0.0038	CcSEcCtD
Bleomycin—LIG1—HIV Life Cycle—ERCC2—skin cancer	0.000365	0.00337	CbGpPWpGaD
Bleomycin—Pruritus—Vismodegib—skin cancer	0.000362	0.00375	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FOXO4—skin cancer	0.000355	0.00329	CbGpPWpGaD
Bleomycin—Flushing—Imiquimod—skin cancer	0.000352	0.00365	CcSEcCtD
Bleomycin—Extravasation—Docetaxel—skin cancer	0.000345	0.00357	CcSEcCtD
Bleomycin—Chills—Imiquimod—skin cancer	0.00034	0.00352	CcSEcCtD
Bleomycin—Disorientation—Fluorouracil—skin cancer	0.000338	0.0035	CcSEcCtD
Bleomycin—Cough—Vemurafenib—skin cancer	0.000338	0.0035	CcSEcCtD
Bleomycin—Alopecia—Imiquimod—skin cancer	0.000335	0.00347	CcSEcCtD
Bleomycin—LIG1—S Phase—CDK4—skin cancer	0.000332	0.00307	CbGpPWpGaD
Bleomycin—Erythema—Imiquimod—skin cancer	0.00033	0.00342	CcSEcCtD
Bleomycin—Myalgia—Vemurafenib—skin cancer	0.000329	0.00341	CcSEcCtD
Bleomycin—Vomiting—Vismodegib—skin cancer	0.000325	0.00337	CcSEcCtD
Bleomycin—Rash—Vismodegib—skin cancer	0.000322	0.00334	CcSEcCtD
Bleomycin—Dermatitis—Vismodegib—skin cancer	0.000322	0.00334	CcSEcCtD
Bleomycin—Anaphylactic shock—Vemurafenib—skin cancer	0.000316	0.00327	CcSEcCtD
Bleomycin—Infection—Vemurafenib—skin cancer	0.000314	0.00325	CcSEcCtD
Bleomycin—Ill-defined disorder—Imiquimod—skin cancer	0.000306	0.00317	CcSEcCtD
Bleomycin—Nausea—Vismodegib—skin cancer	0.000304	0.00315	CcSEcCtD
Bleomycin—Pancytopenia—Dactinomycin—skin cancer	0.000298	0.00309	CcSEcCtD
Bleomycin—Malaise—Imiquimod—skin cancer	0.000298	0.00308	CcSEcCtD
Bleomycin—Hypotension—Vemurafenib—skin cancer	0.000295	0.00306	CcSEcCtD
Bleomycin—Cough—Imiquimod—skin cancer	0.000288	0.00298	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000288	0.00298	CcSEcCtD
Bleomycin—Skin exfoliation—Docetaxel—skin cancer	0.000287	0.00298	CcSEcCtD
Bleomycin—Pneumonia—Dactinomycin—skin cancer	0.000281	0.00292	CcSEcCtD
Bleomycin—Myalgia—Imiquimod—skin cancer	0.000281	0.00291	CcSEcCtD
Bleomycin—Chest pain—Imiquimod—skin cancer	0.000281	0.00291	CcSEcCtD
Bleomycin—Discomfort—Imiquimod—skin cancer	0.000278	0.00288	CcSEcCtD
Bleomycin—Decreased appetite—Vemurafenib—skin cancer	0.000274	0.00284	CcSEcCtD
Bleomycin—Stomatitis—Dactinomycin—skin cancer	0.000273	0.00283	CcSEcCtD
Bleomycin—Pancytopenia—Temozolomide—skin cancer	0.000269	0.00279	CcSEcCtD
Bleomycin—Oedema—Imiquimod—skin cancer	0.000269	0.00279	CcSEcCtD
Bleomycin—Infection—Imiquimod—skin cancer	0.000268	0.00277	CcSEcCtD
Bleomycin—Weight decreased—Temozolomide—skin cancer	0.000257	0.00266	CcSEcCtD
Bleomycin—Anorexia—Imiquimod—skin cancer	0.000257	0.00266	CcSEcCtD
Bleomycin—Pneumonia—Temozolomide—skin cancer	0.000254	0.00264	CcSEcCtD
Bleomycin—Phlebitis—Docetaxel—skin cancer	0.000253	0.00263	CcSEcCtD
Bleomycin—LIG1—HIV Infection—ERCC2—skin cancer	0.000252	0.00233	CbGpPWpGaD
Bleomycin—Body temperature increased—Vemurafenib—skin cancer	0.00025	0.00259	CcSEcCtD
Bleomycin—Pancytopenia—Fluorouracil—skin cancer	0.000248	0.00257	CcSEcCtD
Bleomycin—Stomatitis—Temozolomide—skin cancer	0.000247	0.00256	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000245	0.00254	CcSEcCtD
Bleomycin—Paraesthesia—Imiquimod—skin cancer	0.000242	0.00251	CcSEcCtD
Bleomycin—Dyspnoea—Imiquimod—skin cancer	0.00024	0.00249	CcSEcCtD
Bleomycin—Pneumonia—Fluorouracil—skin cancer	0.000234	0.00243	CcSEcCtD
Bleomycin—Decreased appetite—Imiquimod—skin cancer	0.000234	0.00243	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000233	0.00216	CbGpPWpGaD
Bleomycin—Flushing—Dactinomycin—skin cancer	0.000233	0.00242	CcSEcCtD
Bleomycin—Hypersensitivity—Vemurafenib—skin cancer	0.000233	0.00241	CcSEcCtD
Bleomycin—Pain—Imiquimod—skin cancer	0.00023	0.00239	CcSEcCtD
Bleomycin—Acute coronary syndrome—Fluorouracil—skin cancer	0.00023	0.00238	CcSEcCtD
Bleomycin—Myocardial infarction—Fluorouracil—skin cancer	0.000229	0.00237	CcSEcCtD
Bleomycin—Haemoglobin—Temozolomide—skin cancer	0.000228	0.00237	CcSEcCtD
Bleomycin—Stomatitis—Fluorouracil—skin cancer	0.000227	0.00236	CcSEcCtD
Bleomycin—Haemorrhage—Temozolomide—skin cancer	0.000227	0.00235	CcSEcCtD
Bleomycin—Asthenia—Vemurafenib—skin cancer	0.000227	0.00235	CcSEcCtD
Bleomycin—Hypoaesthesia—Temozolomide—skin cancer	0.000226	0.00234	CcSEcCtD
Bleomycin—Chills—Dactinomycin—skin cancer	0.000225	0.00234	CcSEcCtD
Bleomycin—Pruritus—Vemurafenib—skin cancer	0.000223	0.00232	CcSEcCtD
Bleomycin—Alopecia—Dactinomycin—skin cancer	0.000222	0.0023	CcSEcCtD
Bleomycin—Feeling abnormal—Imiquimod—skin cancer	0.000222	0.0023	CcSEcCtD
Bleomycin—Erythema—Dactinomycin—skin cancer	0.000219	0.00227	CcSEcCtD
Bleomycin—BLMH—Immune System—FOXO4—skin cancer	0.000216	0.00199	CbGpPWpGaD
Bleomycin—Urticaria—Imiquimod—skin cancer	0.000214	0.00222	CcSEcCtD
Bleomycin—Body temperature increased—Imiquimod—skin cancer	0.000213	0.00221	CcSEcCtD
Bleomycin—Flushing—Temozolomide—skin cancer	0.000211	0.00218	CcSEcCtD
Bleomycin—Haemoglobin—Fluorouracil—skin cancer	0.00021	0.00218	CcSEcCtD
Bleomycin—Haemorrhage—Fluorouracil—skin cancer	0.000209	0.00217	CcSEcCtD
Bleomycin—Hypoaesthesia—Fluorouracil—skin cancer	0.000208	0.00216	CcSEcCtD
Bleomycin—Chills—Temozolomide—skin cancer	0.000204	0.00211	CcSEcCtD
Bleomycin—Ill-defined disorder—Dactinomycin—skin cancer	0.000203	0.0021	CcSEcCtD
Bleomycin—Anaemia—Dactinomycin—skin cancer	0.000202	0.00209	CcSEcCtD
Bleomycin—Vomiting—Vemurafenib—skin cancer	0.000201	0.00208	CcSEcCtD
Bleomycin—Alopecia—Temozolomide—skin cancer	0.000201	0.00208	CcSEcCtD
Bleomycin—Rash—Vemurafenib—skin cancer	0.000199	0.00206	CcSEcCtD
Bleomycin—Dermatitis—Vemurafenib—skin cancer	0.000199	0.00206	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MLH1—skin cancer	0.000199	0.00184	CbGpPWpGaD
Bleomycin—Hypersensitivity—Imiquimod—skin cancer	0.000198	0.00206	CcSEcCtD
Bleomycin—Erythema—Temozolomide—skin cancer	0.000198	0.00205	CcSEcCtD
Bleomycin—Malaise—Dactinomycin—skin cancer	0.000197	0.00204	CcSEcCtD
Bleomycin—Leukopenia—Dactinomycin—skin cancer	0.000196	0.00203	CcSEcCtD
Bleomycin—Asthenia—Imiquimod—skin cancer	0.000193	0.002	CcSEcCtD
Bleomycin—Pruritus—Imiquimod—skin cancer	0.000191	0.00197	CcSEcCtD
Bleomycin—Nausea—Vemurafenib—skin cancer	0.000188	0.00194	CcSEcCtD
Bleomycin—Myalgia—Dactinomycin—skin cancer	0.000186	0.00193	CcSEcCtD
Bleomycin—Bronchospasm—Docetaxel—skin cancer	0.000186	0.00192	CcSEcCtD
Bleomycin—Alopecia—Fluorouracil—skin cancer	0.000185	0.00192	CcSEcCtD
Bleomycin—Discomfort—Dactinomycin—skin cancer	0.000184	0.00191	CcSEcCtD
Bleomycin—Ill-defined disorder—Temozolomide—skin cancer	0.000183	0.0019	CcSEcCtD
Bleomycin—Anaemia—Temozolomide—skin cancer	0.000183	0.00189	CcSEcCtD
Bleomycin—Erythema—Fluorouracil—skin cancer	0.000182	0.00189	CcSEcCtD
Bleomycin—Pancytopenia—Docetaxel—skin cancer	0.000179	0.00186	CcSEcCtD
Bleomycin—Oedema—Dactinomycin—skin cancer	0.000178	0.00185	CcSEcCtD
Bleomycin—Malaise—Temozolomide—skin cancer	0.000178	0.00185	CcSEcCtD
Bleomycin—Infection—Dactinomycin—skin cancer	0.000177	0.00184	CcSEcCtD
Bleomycin—Leukopenia—Temozolomide—skin cancer	0.000177	0.00183	CcSEcCtD
Bleomycin—Thrombocytopenia—Dactinomycin—skin cancer	0.000175	0.00181	CcSEcCtD
Bleomycin—Cough—Temozolomide—skin cancer	0.000173	0.00179	CcSEcCtD
Bleomycin—Vomiting—Imiquimod—skin cancer	0.000171	0.00177	CcSEcCtD
Bleomycin—Weight decreased—Docetaxel—skin cancer	0.000171	0.00177	CcSEcCtD
Bleomycin—Anorexia—Dactinomycin—skin cancer	0.00017	0.00176	CcSEcCtD
Bleomycin—Rash—Imiquimod—skin cancer	0.00017	0.00176	CcSEcCtD
Bleomycin—Dermatitis—Imiquimod—skin cancer	0.00017	0.00176	CcSEcCtD
Bleomycin—Pneumonia—Docetaxel—skin cancer	0.000169	0.00175	CcSEcCtD
Bleomycin—Anaemia—Fluorouracil—skin cancer	0.000168	0.00175	CcSEcCtD
Bleomycin—Myalgia—Temozolomide—skin cancer	0.000168	0.00174	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000167	0.00154	CbGpPWpGaD
Bleomycin—Discomfort—Temozolomide—skin cancer	0.000166	0.00172	CcSEcCtD
Bleomycin—Acute coronary syndrome—Docetaxel—skin cancer	0.000166	0.00172	CcSEcCtD
Bleomycin—Myocardial infarction—Docetaxel—skin cancer	0.000165	0.00171	CcSEcCtD
Bleomycin—Stomatitis—Docetaxel—skin cancer	0.000164	0.0017	CcSEcCtD
Bleomycin—Leukopenia—Fluorouracil—skin cancer	0.000163	0.00169	CcSEcCtD
Bleomycin—Confusional state—Temozolomide—skin cancer	0.000163	0.00169	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000163	0.00168	CcSEcCtD
Bleomycin—Anaphylactic shock—Temozolomide—skin cancer	0.000161	0.00167	CcSEcCtD
Bleomycin—Oedema—Temozolomide—skin cancer	0.000161	0.00167	CcSEcCtD
Bleomycin—Infection—Temozolomide—skin cancer	0.00016	0.00166	CcSEcCtD
Bleomycin—Nausea—Imiquimod—skin cancer	0.00016	0.00166	CcSEcCtD
Bleomycin—Thrombocytopenia—Temozolomide—skin cancer	0.000158	0.00164	CcSEcCtD
Bleomycin—LIG1—Disease—CSPG4—skin cancer	0.000156	0.00145	CbGpPWpGaD
Bleomycin—Myalgia—Fluorouracil—skin cancer	0.000155	0.00161	CcSEcCtD
Bleomycin—Chest pain—Fluorouracil—skin cancer	0.000155	0.00161	CcSEcCtD
Bleomycin—Decreased appetite—Dactinomycin—skin cancer	0.000155	0.00161	CcSEcCtD
Bleomycin—Anorexia—Temozolomide—skin cancer	0.000154	0.00159	CcSEcCtD
Bleomycin—Discomfort—Fluorouracil—skin cancer	0.000153	0.00159	CcSEcCtD
Bleomycin—Pain—Dactinomycin—skin cancer	0.000153	0.00158	CcSEcCtD
Bleomycin—Haemoglobin—Docetaxel—skin cancer	0.000152	0.00157	CcSEcCtD
Bleomycin—Haemorrhage—Docetaxel—skin cancer	0.000151	0.00157	CcSEcCtD
Bleomycin—Hypoaesthesia—Docetaxel—skin cancer	0.00015	0.00156	CcSEcCtD
Bleomycin—Confusional state—Fluorouracil—skin cancer	0.00015	0.00155	CcSEcCtD
Bleomycin—Oedema—Fluorouracil—skin cancer	0.000149	0.00154	CcSEcCtD
Bleomycin—Anaphylactic shock—Fluorouracil—skin cancer	0.000149	0.00154	CcSEcCtD
Bleomycin—Infection—Fluorouracil—skin cancer	0.000148	0.00153	CcSEcCtD
Bleomycin—Feeling abnormal—Dactinomycin—skin cancer	0.000147	0.00152	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000147	0.00152	CcSEcCtD
Bleomycin—Thrombocytopenia—Fluorouracil—skin cancer	0.000146	0.00151	CcSEcCtD
Bleomycin—Paraesthesia—Temozolomide—skin cancer	0.000145	0.0015	CcSEcCtD
Bleomycin—Dyspnoea—Temozolomide—skin cancer	0.000144	0.00149	CcSEcCtD
Bleomycin—Anorexia—Fluorouracil—skin cancer	0.000142	0.00147	CcSEcCtD
Bleomycin—Body temperature increased—Dactinomycin—skin cancer	0.000141	0.00146	CcSEcCtD
Bleomycin—Decreased appetite—Temozolomide—skin cancer	0.00014	0.00145	CcSEcCtD
Bleomycin—Flushing—Docetaxel—skin cancer	0.00014	0.00145	CcSEcCtD
Bleomycin—Hypotension—Fluorouracil—skin cancer	0.000139	0.00144	CcSEcCtD
Bleomycin—Pain—Temozolomide—skin cancer	0.000138	0.00143	CcSEcCtD
Bleomycin—Chills—Docetaxel—skin cancer	0.000136	0.0014	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000135	0.0014	CcSEcCtD
Bleomycin—Paraesthesia—Fluorouracil—skin cancer	0.000134	0.00138	CcSEcCtD
Bleomycin—Alopecia—Docetaxel—skin cancer	0.000133	0.00138	CcSEcCtD
Bleomycin—Feeling abnormal—Temozolomide—skin cancer	0.000133	0.00138	CcSEcCtD
Bleomycin—Dyspnoea—Fluorouracil—skin cancer	0.000133	0.00137	CcSEcCtD
Bleomycin—Erythema—Docetaxel—skin cancer	0.000131	0.00136	CcSEcCtD
Bleomycin—Hypersensitivity—Dactinomycin—skin cancer	0.000131	0.00136	CcSEcCtD
Bleomycin—Decreased appetite—Fluorouracil—skin cancer	0.000129	0.00134	CcSEcCtD
Bleomycin—Urticaria—Temozolomide—skin cancer	0.000128	0.00133	CcSEcCtD
Bleomycin—Asthenia—Dactinomycin—skin cancer	0.000128	0.00133	CcSEcCtD
Bleomycin—Body temperature increased—Temozolomide—skin cancer	0.000128	0.00132	CcSEcCtD
Bleomycin—Pain—Fluorouracil—skin cancer	0.000127	0.00132	CcSEcCtD
Bleomycin—Feeling abnormal—Fluorouracil—skin cancer	0.000123	0.00127	CcSEcCtD
Bleomycin—Anaemia—Docetaxel—skin cancer	0.000122	0.00126	CcSEcCtD
Bleomycin—Hypersensitivity—Temozolomide—skin cancer	0.000119	0.00123	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—NRAS—skin cancer	0.000118	0.00109	CbGpPWpGaD
Bleomycin—Urticaria—Fluorouracil—skin cancer	0.000118	0.00122	CcSEcCtD
Bleomycin—Leukopenia—Docetaxel—skin cancer	0.000118	0.00122	CcSEcCtD
Bleomycin—Body temperature increased—Fluorouracil—skin cancer	0.000118	0.00122	CcSEcCtD
Bleomycin—Asthenia—Temozolomide—skin cancer	0.000116	0.0012	CcSEcCtD
Bleomycin—Cough—Docetaxel—skin cancer	0.000115	0.00119	CcSEcCtD
Bleomycin—Pruritus—Temozolomide—skin cancer	0.000114	0.00118	CcSEcCtD
Bleomycin—Vomiting—Dactinomycin—skin cancer	0.000113	0.00118	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDK4—skin cancer	0.000113	0.00104	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TERT—skin cancer	0.000113	0.00104	CbGpPWpGaD
Bleomycin—Rash—Dactinomycin—skin cancer	0.000112	0.00117	CcSEcCtD
Bleomycin—Chest pain—Docetaxel—skin cancer	0.000112	0.00116	CcSEcCtD
Bleomycin—Myalgia—Docetaxel—skin cancer	0.000112	0.00116	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000112	0.00103	CbGpPWpGaD
Bleomycin—Hypersensitivity—Fluorouracil—skin cancer	0.00011	0.00114	CcSEcCtD
Bleomycin—Confusional state—Docetaxel—skin cancer	0.000108	0.00112	CcSEcCtD
Bleomycin—Anaphylactic shock—Docetaxel—skin cancer	0.000107	0.00111	CcSEcCtD
Bleomycin—Oedema—Docetaxel—skin cancer	0.000107	0.00111	CcSEcCtD
Bleomycin—Infection—Docetaxel—skin cancer	0.000107	0.0011	CcSEcCtD
Bleomycin—LIG1—Disease—ENO2—skin cancer	0.000106	0.000983	CbGpPWpGaD
Bleomycin—LIG1—Disease—SHH—skin cancer	0.000106	0.000983	CbGpPWpGaD
Bleomycin—Nausea—Dactinomycin—skin cancer	0.000106	0.0011	CcSEcCtD
Bleomycin—Pruritus—Fluorouracil—skin cancer	0.000105	0.00109	CcSEcCtD
Bleomycin—Thrombocytopenia—Docetaxel—skin cancer	0.000105	0.00109	CcSEcCtD
Bleomycin—Vomiting—Temozolomide—skin cancer	0.000103	0.00106	CcSEcCtD
Bleomycin—Anorexia—Docetaxel—skin cancer	0.000102	0.00106	CcSEcCtD
Bleomycin—Rash—Temozolomide—skin cancer	0.000102	0.00105	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KRAS—skin cancer	0.000102	0.000941	CbGpPWpGaD
Bleomycin—Dermatitis—Temozolomide—skin cancer	0.000102	0.00105	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDK4—skin cancer	0.000101	0.000934	CbGpPWpGaD
Bleomycin—Hypotension—Docetaxel—skin cancer	0.0001	0.00104	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	9.92e-05	0.000918	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Docetaxel—skin cancer	9.78e-05	0.00101	CcSEcCtD
Bleomycin—Paraesthesia—Docetaxel—skin cancer	9.64e-05	0.000999	CcSEcCtD
Bleomycin—Nausea—Temozolomide—skin cancer	9.58e-05	0.000993	CcSEcCtD
Bleomycin—Dyspnoea—Docetaxel—skin cancer	9.57e-05	0.000992	CcSEcCtD
Bleomycin—Vomiting—Fluorouracil—skin cancer	9.45e-05	0.00098	CcSEcCtD
Bleomycin—Rash—Fluorouracil—skin cancer	9.37e-05	0.000972	CcSEcCtD
Bleomycin—Dermatitis—Fluorouracil—skin cancer	9.37e-05	0.000971	CcSEcCtD
Bleomycin—Decreased appetite—Docetaxel—skin cancer	9.33e-05	0.000967	CcSEcCtD
Bleomycin—Pain—Docetaxel—skin cancer	9.18e-05	0.000951	CcSEcCtD
Bleomycin—Feeling abnormal—Docetaxel—skin cancer	8.84e-05	0.000917	CcSEcCtD
Bleomycin—Nausea—Fluorouracil—skin cancer	8.83e-05	0.000915	CcSEcCtD
Bleomycin—LIG1—Disease—FOXO4—skin cancer	8.67e-05	0.000802	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—HRAS—skin cancer	8.65e-05	0.0008	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2A—skin cancer	8.63e-05	0.000798	CbGpPWpGaD
Bleomycin—Body temperature increased—Docetaxel—skin cancer	8.48e-05	0.000879	CcSEcCtD
Bleomycin—Hypersensitivity—Docetaxel—skin cancer	7.91e-05	0.000819	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDKN2A—skin cancer	7.72e-05	0.000714	CbGpPWpGaD
Bleomycin—Asthenia—Docetaxel—skin cancer	7.7e-05	0.000798	CcSEcCtD
Bleomycin—Pruritus—Docetaxel—skin cancer	7.59e-05	0.000787	CcSEcCtD
Bleomycin—BLMH—Immune System—NRAS—skin cancer	7.17e-05	0.000663	CbGpPWpGaD
Bleomycin—Vomiting—Docetaxel—skin cancer	6.82e-05	0.000707	CcSEcCtD
Bleomycin—Rash—Docetaxel—skin cancer	6.77e-05	0.000701	CcSEcCtD
Bleomycin—Dermatitis—Docetaxel—skin cancer	6.76e-05	0.000701	CcSEcCtD
Bleomycin—Nausea—Docetaxel—skin cancer	6.37e-05	0.000661	CcSEcCtD
Bleomycin—LIG1—Disease—ERCC2—skin cancer	6.17e-05	0.000571	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KRAS—skin cancer	6.17e-05	0.000571	CbGpPWpGaD
Bleomycin—LIG1—Disease—TERT—skin cancer	5.79e-05	0.000535	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HRAS—skin cancer	5.24e-05	0.000485	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL6—skin cancer	5.02e-05	0.000464	CbGpPWpGaD
Bleomycin—LIG1—Disease—BRAF—skin cancer	4.58e-05	0.000424	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TP53—skin cancer	4.3e-05	0.000397	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTGS2—skin cancer	3.7e-05	0.000342	CbGpPWpGaD
Bleomycin—LIG1—Disease—NRAS—skin cancer	2.88e-05	0.000266	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—skin cancer	2.48e-05	0.000229	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—skin cancer	2.11e-05	0.000195	CbGpPWpGaD
Bleomycin—LIG1—Disease—IL6—skin cancer	2.02e-05	0.000187	CbGpPWpGaD
